Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$43.12
-1.27-2.86%
Last update: Oct 16, 4:19 PM
$43.11
-1.28-2.88%
Veracyte Inc (VCYT) Stock Price, Quote, News & History
VCYTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Other companies in Veracyte’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Veracyte has a consensus price target of $52.21.
The stock price for Veracyte (NASDAQ: VCYT) is $43.11 last updated October 16, 2026 at 4:19 PM EDT.
There are no upcoming dividends for Veracyte.
Veracyte does not have any upcoming earnings scheduled.
There is no upcoming split for Veracyte.
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
